<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	







  
  
  	
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
	<div class=WordSection1>
<h2><span lang=EN-US style='font-size:14.0pt'>Fungal skin infections</span></h2>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>Common fungal skin infections in our
environment include:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tinea pedis</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tinea cruris</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tinea corporis</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tinea capitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cutaneous candidiasis </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pityriasis versicolor</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seborrhoeic dermatitis</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nail infections</span></p>
<h2><span lang=EN-US>Target users</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Gate clinic</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes</span></h2>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><span
lang=EN-US>This guideline outlines the management of fungal skin infections in
our setting. In most cases topicals can be used in order to reduce the side
effects of systemic treatment. Patients must be encouraged to continue
treatment until the lesions have disappeared and then for a further week to
reduce the incidence of treatment failure.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><span
lang=EN-US>Terbinafine is not provided at the clinic and may be unaffordable
for most patients. </span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span lang=EN-US>Most fungal skin infections present with an
itchy rash.</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><b><u><span
lang=EN-US>Tinea pedis</span></u><span lang=EN-US>:</span></b><span lang=EN-US>
Itching and/or burning sensation in the feet. It may present as:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Interdigital: toe-web infection, usually occurs
between two smallest toes with redness, blisters or softening and breaking down
of the skin</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Moccasin: involves the entire sole of the foot
and extend to the sides of the foot  with peeling, cracking and scaling of the
feet</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Vesicular: fluid-filled blisters on the
underside of the foot, the toes, the heel or on top of the foot</span></p>
<p class=MsoNormal><b><u><span lang=EN-US>Tinea cruris</span></u><span
lang=EN-US>:</span></b><span lang=EN-US> Affects genitals, inner thighs and
buttocks. It appears as a red, scaly, itchy rash that is often ring-shaped. It
is mildly contagious</span></p>
<p class=MsoNormal><b><u><span lang=EN-US>Tinea corporis</span></u><span
lang=EN-US>:</span></b><span lang=EN-US>  Occurs anywhere on the body. Each
lesion is circular, red, scaly flat lesion. The outer part of the rash is
raised while the skin in the middle appears normal. Lesions may coalesce. It is
contagious.</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><b><u><span
lang=EN-US>Tinea capitis</span></u><span lang=EN-US>:</span></b><span
lang=EN-US>  Affects the scalp and is most common in children. It is contagious
and facilitated by overcrowding and poor hygiene. Features include:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Itchy patches on the scalp, scaly, red areas
with bald spots</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Broken off hair</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Brittle hair</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Painful scalp</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Crusty swellings which may become bacterially infected
(kerion)</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Swollen cervical lymph nodes</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:66.05pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Low grade fever</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><b><u><span
lang=EN-US>Cutaneous candidiasis</span></u><span lang=EN-US>:</span></b><span
lang=EN-US>  Affects nearly any skin surface of the body but most common in
warm, moist areas in contact such as the armpits, breast folds  and groin. They
are common among obese people, diabetics and people on antibiotics. In
children, it causes a diaper rash. It presents as itchy or burning red patches
that may ooze clear fluid with some  surrounding pimple-like bumps. Other
presentations include oral/vaginal thrush and nail infection. It is not
contagious</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><b><u><span
lang=EN-US>Pityriasis (tinea) versicolor</span></u></b><span lang=EN-US>: Common
among teenagers and young adults. It presents as multiple hypopigmented (light)
or hyperpigmented (dark) scaly, dry patches usually over the face, neck, upper
arms and trunk. The lesions may be itchy. It is not contagious.</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><b><u><span
lang=EN-US>Seborrhoeic dermatitis</span></u></b><span lang=EN-US>: Presents on
the scalp as dandruff. It also involves the face, neck, trunk and any other
hair-bearing area presenting as scaly hypopigmented or red patches. It is not
contagious.</span></p>
<b><u><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span></u></b>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><b><u><span
lang=EN-US>Nail Infections (onychomycosis):</span></u></b><span lang=EN-US> May
present as thickened and discolored nails. Nails may become, black, yellow or
green. The nail may be brittle and may separate from the nail bed. The
underlying skin may become inflamed and infected.</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><span
lang=EN-US>If a Cutaneous dermatophyte infection is misdiagnosed and initially
treated with a topical corticosteroid, the appearance of the infection may be
altered, making diagnosis more difficult (i.e., tinea incognito). Patients can
develop diminished erythema and scale, loss of a well-defined border,
exacerbation of disease, or a deep-seated folliculitis (Majocchi's granuloma).</span></p>
<p class=MsoNormal style='margin-bottom:8.0pt;line-height:107%'><span
lang=EN-US>The simultaneous presence of more than one type of dermatophyte
infection is common (e.g. tinea pedis and tinea cruris or tinea pedis and tinea
unguium). Performance of a full skin examination including the skin, hair, and
nails aids in the detection of additional sites of infection. Occasionally,
patients develop a dermatophytid reaction, a secondary dermatitic reaction at a
distant site that may reflect an immunologic reaction to the infection.</span></p>
<h2><span lang=EN-US>Management in Gate clinic</span></h2>
<p class=MsoNormal><span lang=EN-US>Most fungal skin infections can be treated
with topical antifungals. Clotrimazole or miconazole cream can be applied
thinly twice daily over localized lesions. </span></p>
<p class=MsoNormal><span lang=EN-US>Seborrhoeic dermatitis and pityriasis
versicolor can be treated with either ketoconazole shampoo or selenium sulfide
shampoo applied to lesions twice weekly. Skin lesions in seborrhoeic dermatitis
can also be treated with 1% hydrocortisone cream twice each day until healing
occurs. </span></p>
<p class=MsoNormal><span lang=EN-US>Tinea capitis can be treated with Whitfield’s
ointment applied twice daily. Add cloxacillin 20-25 mg/kg (max 500 mg) QDS for
5 days if kerion is present.</span></p>
<p class=MsoNormal><b><span lang=EN-US>DO NOT</span></b><span lang=EN-US>
prescribe griseofulvin – as it is teratogenic even up to six months after
conception. This is true for both men and women.</span></p>
<p class=MsoNormal><span lang=EN-US>Review patients after 4 weeks of treatment
to asses improvement. If rash shows some improvement, ask patient to continue
treat treatment until one week after lesions have cleared.</span></p>
<p class=MsoNormal><span lang=EN-US>Refer patients to the doctor if:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Immunosuppressed (HIV, Diabetes mellitus)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Widespread rash</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Unfamiliar rash / Rash does not appear typical</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>No improvement after 4 weeks of treatment
(except nail infections and pityriasis versicolor)</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nail infections</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Management in OPD</span></h2>
<p class=MsoNormal><span lang=EN-US>For patients with widespread rash, atypical
rash or minimal improvement on topical therapy, consider alternative diagnosis
or background immunosuppression.</span></p>
<p class=MsoNormal><span lang=EN-US>HIV testing, VDRL, Fasting blood glucose
may assist in diagnosis of unusual rash.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients with fungal skin infections and
immunosuppression may require systemic(oral) therapy. Options include
fluconazole (continuous or pulse therapy), itraconazole or terbinafine. Drug
interactions, contra-indications and adverse effects must be considered in drug
choice.</span></p>
<p class=MsoNormal><span lang=EN-US>Nail Infections: account for less than half
of all nail lesions. Treatment of onychomycosis is not mandatory in all
patients. Weigh the risk of treatment against potential benefit for each
individual patient.</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:74.2pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Oral – terbinafine (76% effective), itraconazole
(60% effective), or fluconazole (48 % effective). Oral ketoconazole is not usually
recommended due to side effects and the need for a long course of treatment. However,
it is often the only effective and affordable option in our setting. DO NOT
prescribe griseofulvin (see note above).</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:8.0pt;margin-left:74.2pt;text-indent:-18.0pt;line-height:107%'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Others – chemical keratolytic agents (e.g. urea
cream), surgical debridement of the affected nails.</span></p>
<p class=MsoNormal><b><span lang=EN-US style='font-size:14.0pt'>References</span></b></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Gupta AK1,
Drummond-Main C, Paquet M. Evidence-based optimal fluconazole dosing regimen
for onychomycosis treatment. </span><span lang=EN-US><a
href="https://www.ncbi.nlm.nih.gov/pubmed/22694221"
title="The Journal of dermatological treatment."><span style='font-size:10.0pt;
color:windowtext;text-decoration:none'>J Dermatolog Treat.</span></a></span><span
lang=EN-US style='font-size:10.0pt'> 2013 Feb;24(1):75-80. doi:
10.3109/09546634.2012.703308</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Rajagopalan M,
Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, Godse K, Patel K,
Rengasamy M, Rudramurthy S, Dogra S. Expert consensus on the management of
dermatophytosis in India (ECTODERM India). BMC dermatology. 2018 Dec;18(1):6.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&nbsp;</span></p>
<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: </span><span lang=EN-US>Danlami Garba</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 28 August 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Fatai Akemokwe</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 12 September 2018 </span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
